Академический Документы
Профессиональный Документы
Культура Документы
1. Zaidman, B., Yassin, M., Mahajna, J., & Wasser, S. (2005). Medicinal mushroom modulators of
molecular targets as cancer therapeutics. Applied Microbiology and Biotechnology, 67(4),
453-468.
https://link-springer-com.libproxy.csun.edu/article/10.1007/s00253-004-1787-z
❖ Mushroom-extracted compounds are commonly used as immunomodulators or as biological
response modifiers (BRM). The basic strategy underlying immunomodulation is to identify
aspects of the host response that can be enhanced or suppressed in such a way as to augment or
complement a desired immune response.
❖ Whether certain compounds enhance or suppress immune responses depends on a number of
factors, including dose, route of administration, timing of administration of the compound,
mechanism of action, and site of activity.
2. Amy Putiri, Leanna J. Standish, Juliette Gay, Cynthia A. Wenner, Masa Sasagawa, Erin Sweet, . .
. Carolyn J. Torkelson. (2012). Phase 1 Clinical Trial of Trametes versicolor in Women with
Breast Cancer. ISRN Oncology,2012, 251632-251632.
https://www.hindawi.com/journals/isrn/2012/251632/
❖ Orally administered preparations from the Trametes versicolor (Tv) mushroom have been
hypothesized to improve immune response in women with breast cancer after standard
chemotherapy and radiotherapy.
❖ Eleven participants were recruited and nine women completed the study. Each cohort was
comprised of three participants given one of three doses of Tv (3, 6, or 9 grams).
❖ Immune data was collected pre- and post radiation, at 3 on-treatment time points and after a
3-week washout
❖ Nine adverse events were reported (7 mild, 1 moderate, and 1 severe), suggesting that Tv was
well tolerated. Immunological results indicated trends in (1) increased lymphocyte counts at 6 and
9 grams/day; (2) increased natural killer cell functional activity at 6 grams/day; (3) dose-related
increases in CD8+ T cells and CD19+ B cells , but not CD4+ T cells or CD16+56+ NK cells.
❖ These findings show that up to 9 grams/day of a Tv preparation is safe and tolerable in women
with breast cancer in the postprimary treatment setting. This Tv preparation may improve
immune status in immunocompromised breast cancer patients following standard primary
oncologic treatment.
3. Stamets, P. (2012). Trametes versicolor (Turkey Tail Mushrooms) and the Treatment of Breast
Cancer. Global Advances in Health and Medicine, 1(5), 20.
https://csun-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_sagej10.7453_gahmj.2
012.1.5.007&context=PC&vid=01CALS_UNO&lang=en_US&search_scope=EVERYTHING&adaptor=
primo_central_multiple_fe&tab=everything&query=any,contains,turkey%20tail%20cancer&sortby=rank
&offset=0
❖ 83 yo woman diagnosed with metastatic inflammatory breast cancer
❖ Chemotherapy was initiated with Taxol and Herceptin, and consumption of
capsules of turkey tail mushroom daily.
❖ The dose was 4 g twice daily (“Host Defense Turkey Tail” capsules, Fungi Perfecti
Laboratories, Kamilche Point, Washington).
❖ Capsules consist of activated, freeze-dried, organic mushroom mycelium, containing
polysaccharides (beta-glucans, arabinoxylane, glucose, xylose, galactose, mannose,
glycoproteins, ergosterols, triterpenoids, and other myconutrients).
❖ Once chemotherapy ended and Herceptin was initiated, Turkey Tail supplementation was still
being practiced
❖ Results: The most intriguing part of this study was the finding that 6 g of T versicolor appeared to
lead to faster immune recovery after radiotherapy. This should be studied in additional clinical
trials on the potential primary and secondary effects of mushroom therapy in patients with cancer
and, more specifically, cancers with altered CR3 membrane receptors
1. Goel, Amit, Ahmad, Farhan Jalees, Singh, Raman Mohan, & Singh, Gyanendra Nath. (2010).
3-Acetyl-11-keto-β-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory
and anti-arthritic activity. Journal of Pharmacy and Pharmacology, 62(2), 273-278.
http://onlinelibrary.wiley.com.libproxy.csun.edu/doi/10.1211/jpp.62.02.0016/full
❖ This study found different ways to synthesize AKBA and found that creation by means of
transmission electron microscopy and dynamic light scattering were most successful in creating
an AKBA product that acts primarily as an anti-inflammatory substance.
❖ This study suggested that AKBA polymeric nanomicelle gel significantly enhanced skin
permeability, and anti-inflammatory and anti-arthritic activity.
2. Meka, Ravada, Murali Krishna Kumar, Purna Nagasree, & Golakoti. (2017). Synthesis of new
analogs of AKBA and evaluation of their anti-inflammatory activities. Bioorganic & Medicinal
Chemistry, 25(4), 1374-1388.
https://www-sciencedirect-com.libproxy.csun.edu/science/article/pii/S0968089616310756
❖ A new series of 11-keto-β-boswellic acid and 3-O-acetyl-11-keto-β-boswellic acid analogs (5, 7,
8, 10, 13, 18a-d, 27a-c, 28a-d) were synthesized by modification of hydroxyl and acid functional
moieties of boswellic acids.
❖ The structures of these analogs were confirmed by spectral data analysis (1H, 13C NMR and
mass). Compounds 18b, 27a and 8 showed potent 5-lipoxygenase enzyme inhibitory activity.
❖ The computational studies revealed that selectivity of AKBA is due to its fitment into the 5-LOX
receptor, which is missing for the other enzymes like 12-LOX, COX-1 and COX-2.
❖ This study found potentiating effects of 2-formyl and 3-keto substituents in reviving inactive
AKBA analogues possessing essential COOH group at 4th position.
❖ The anti-inflammatory potential of the synthesized compounds was further evaluated by the
docking studies with crystal structure of 5-LOX, the dock score and dock pose were analyzed for
clear understanding of probable interactions of synthesized compounds with the enzyme. The
dock scores obtained are in good correlation with the bioactivity results. All the bioactive
compounds showed strong interactions with the active site amino acids His 367 and His 372.